Descriptor English: | Eosinophilia-Myalgia Syndrome | ||||
Descriptor Spanish: |
Síndrome de Eosinofilia-Mialgia
| ||||
Descriptor Portuguese: | Síndrome de Eosinofilia-Mialgia | ||||
Descriptor French: | Syndrome éosinophilie-myalgie | ||||
Entry term(s): |
Eosinophilia Myalgia Syndrome Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related Eosinophilia-Myalgia Syndromes Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related L-Tryptophan-Related Eosinophilia-Myalgia Syndrome L-Tryptophan-Related Eosinophilia-Myalgia Syndromes Syndrome, Eosinophilia-Myalgia Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related Syndrome, L-Tryptophan-Related Eosinophilia-Myalgia Syndromes, Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related Eosinophilia-Myalgia |
||||
Tree number(s): |
C05.651.290 C10.668.491.050 C15.378.553.231.335 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016603 | ||||
Scope note: | A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93) |
||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||
Previous Indexing: |
Eosinophilia/chemically induced (1989-1990) Muscular Diseases/chemically induced (1990) Tryptophan/adverse effects (1989-1990) |
||||
Public MeSH Note: | 92 |
||||
History Note: | 92 |
||||
DeCS ID: | 30124 | ||||
Unique ID: | D016603 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1992/01/01 | ||||
Date of Entry: | 1991/01/25 | ||||
Revision Date: | 2018/06/30 |
|
Eosinophilia-Myalgia Syndrome
- Preferred
Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related
- Narrower
Concept UI |
M0025320 |
Scope note | A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93) |
Preferred term | Eosinophilia-Myalgia Syndrome |
Entry term(s) |
Eosinophilia Myalgia Syndrome Eosinophilia-Myalgia Syndromes Syndrome, Eosinophilia-Myalgia Syndromes, Eosinophilia-Myalgia |
Concept UI |
M0335638 |
Preferred term | Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related |
Entry term(s) |
Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related L-Tryptophan-Related Eosinophilia-Myalgia Syndrome L-Tryptophan-Related Eosinophilia-Myalgia Syndromes Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related Syndrome, L-Tryptophan-Related Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related Eosinophilia-Myalgia |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey